Deciphera Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
Deciphera Pharmaceuticals, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number of 6.88 million shares as of 2023-12-31, per its 10-K filed 2024-02-07.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber · last filed 2024-02-07
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 6.88M shares.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 5.17M shares.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 3.60M shares.
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 2.87M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number |
|---|---|
| 2023-12-31 | 6.88M shares 10-K · filed 2024-02-07 |
| 2022-12-31 | 5.17M shares 10-K · filed 2023-02-07 |
| 2021-12-31 | 3.60M shares 10-K · filed 2022-02-08 |
| 2020-12-31 | 2.87M shares 10-K · filed 2021-02-09 |
| 2019-12-31 | 3.05M shares 10-K · filed 2020-03-09 |
| 2018-12-31 | 3.31M shares 10-K · filed 2019-03-14 |
| 2017-12-31 | 2.44M shares 10-K · filed 2018-03-28 |